Posts tagged gender
30 day use of e-cigarettes by youth up 500%
Adoption of motion for resolution
Principle of equal pay for male and female workers for equal work or work of equal value is still a
persistent problem and currently stands at 16.2% across the EU.
Members have tabled 13 amendments to the draft motion for a resolution winding up oral question to the European Commission on the issue of closing the gender pay gap. The Committee will vote on the draft motion for a resolution and the amendments.…more
Invisible and at Risk: STDs in Young Adult Sexual Minority Women in U.S.
Sexual minority women are not adequately assessed by national STD surveillance systems, and research regarding STD burden in nationally representative samples of such women is rare. Moreover, few studies have assessed STD risk exclusively among young adult women.
Wave 4 (2007–2008) data from the National Longitudinal Study of Adolescent Health on 7,296 females aged 24–32 were used to examine the relationship between sexual orientation and receipt of an STD diagnosis in the past year. Multivariate logistic regression analyses used two measures of sexual orientation: sexual identity and gender of sex partners.
Eighty percent of women considered themselves straight; 16% mostly straight; and 4% bisexual, mostly gay or gay. Eighty-five percent had had only male partners, while 7% had had one female partner, and 8% two or more female partners.
In unadjusted models, women who identified themselves as mostly straight were more likely than straight women to have had an STD (odds ratio, 1.4); mostly gay or gay women were at lower risk (0.4). Women who had had two or more female partners had a higher STD risk than did women who had had only male partners (1.7). Adjusting for social and demographic characteristics did not substantially alter these results; however, the associations between sexual identity, gender of sex partners and STD diagnosis were eliminated after adjustment for sexual behaviors (e.g., having had anal sex).
Sexual identity, gender of sex partners and sexual behaviors should be taken into account in assessments of women’s STD risk. ...more
Perspectives on Sexual and Reproductive Health, 2013, 45(2):66–73, doi: 10.1363/4506613 By Lisa L. Lindley, Katrina M. Walsemann, Jarvis W. Carter Jr.
European Week Against Cancer: 29 May 2013, Aviva Stadium, Dublin, Ireland
In support of the European Week Against Cancer and in celebration of the Irish Presidency of the Council of the European Union, the European Institute of Women’s Health (EIWH) held a workshop entitled “Mind the Gender Gap: Smoking and Drinking in Girls and Women” at the Irish Cancer Society’s Healthy Lifestyle for Cancer Prevention Conference. The workshop, bringing together European and Irish experts in the field, sounded the alert about the serious health challenges facing women in the future due to their increasing consumption of tobacco and alcohol.
Speakers and delegates attending the EIWH’s workshop applauded the Irish Minister of Health, Dr. James Reilly’s announcement yesterday that Ireland will introduce plain packets for cigarettes and other tobacco products. It is expected that the new legislation will be in place by early next year. Minister Reilly stated that, standardised packaging will “remove the final way for Tobacco companies to promote their deadly product in Ireland.”1
Cancer is a major killer of European women and men. Yet, many people are unaware that some cancers can be prevented. The WHO estimates that about 40% of cancers are preventable. However, much depends on us, the citizens of Europe, how well we are informed about appropriate prevention measures and healthy lifestyles and if we are willing to act on evidence-based advice to change our behaviour. The European Week against Cancer presents each year an opportunity to highlight the European Code against Cancer, which sets out the major steps for evidence-based cancer prevention. The Code provides guidance, advice and encouragement for people to adopt healthy lifestyle and take appropriate action right now.
In the past, mostly men drove smoking and drinking trends, but with the changing societal role of women, their empowerment, emancipation, and fuelled by the tobacco and alcohol industries’ clever marketing tactics, more and more women are taking on what used to be considered male lifestyles. Smoking and binge drinking are becoming alarming risk factors for the health of women not only in Ireland, but also across the whole of Europe. “These behaviours threaten not only the future health of women, but also affect their children’s health; this is the reason why we are raising these issues at our workshop today,” explained Peggy Maguire, Director General of the EIWH.
Smoking is the leading cause of preventable disease and death in Europe for women and men.
Gerhard Steffes, Policy Officer of the Programme and Knowledge Management Unit at the Directorate for Health and Consumers (DG SANCO) presented the creative Commission initiative entitled “Ex-smokers are unstoppable.” This programme has been rolled out across Europe and targets young smokers through positive prevention messages and images of young people who state their reasons for giving up smoking. The Ex-smokers initiative supports these individuals in their efforts to stop smoking.
“During the last decades, smoking has become more popular among younger women with potentially disastrous consequences for their future health,” said Joanne Vance, the Senior Health Promotion Officer at the Irish Cancer Society. Although overall the smoking prevalence is lower among women than men, the smoking gap has been narrowing across the EU-27 due to a decrease in male and an alarming increase in female smokers, with up 50% of women now smoking in some European countries. Women appear to smoke for different reasons than men. Research suggests that women get locked into the habit faster and experience more difficulty stopping. They also seem to be more vulnerable to passive or environmental smoke.
Smoking is a major risk for a long list of cancers in women, including those of the lung, mouth and throat, stomach, colon, pancreas, liver and kidney, as well as female-specific cancers of the cervix, ovary and breast. Lung cancer—once considered a male cancer—is now overtaking that of breast cancer in Poland, England and Ireland. Linda Bauld, Professor of Health Policy at the University of Stirling, recommended: “We need to maximised access to effective support to stop smoking for women, but we also need prevent the tobacco industry from promoting cigarettes to women as an attractive product. A key policy is plain packaging, and I am delighted that Ireland has just now announced that it intends to be the first country in Europe to ban branding from cigarette packaging.”
The picture around alcohol consumption in young girls and women is echoing in many ways trends in the smoking field. More and more young women are adopting a lifestyle that includes drinking. Over 1/5 of Europeans aged 15 and older binge drink at least once a week. Alcohol is the third leading risk factor for disease and death after tobacco use and high blood pressure. Globally, the European Region has the highest proportion of ill health (7%) and early death due to alcohol. Historically, women have consumed alcohol less often and to lower amounts than men, but times are changing with relaxing of social taboos and increasing independence, women are adopting drinking as a lifestyle. “Disturbingly, the gender gap between men and women in binge drinking has shrunk on average from 12% in 1995 to 5% in 2011 with regard to binge drinking among youth. Irish girls had higher binge drinking rates compared to boys,” said Joe Barry, Professor of Population Health Medicine at Trinity College Dublin.2
Alcohol consumption is connected to over 60 diseases and health issues. For example, it increases women’s risk of breast cancer, a cancer many women know and fear. Women are more vulnerable to the effects of alcohol than men due to the biological factors of their body structure. Even at a low consumption rate, women still run the risk of many diseases, could endanger their own life through risky behavior such as getting involved in traffic accidents, engage in unsafe sex, exposing themselves to rape and unwanted pregnancy. Among the many different gender issues of alcohol consumption, drinking during pregnancy is a threat to the health of both the mother and of the child. “Our advice to women is to stop alcohol consumption when trying to conceive and during pregnancy, as there is no safe way of drinking for mother and child health,” said Mariann Skar, General Secretary for the European Alcohol Policy Alliance.
Hildrun Sundseth, Board Member of the EIWH summed up the lively audience discussion: “We must tackle smoking and alcohol consumption in women and men forcefully, by taking account of biological and behavioural factors. Robust market regulation of these products, flanked by gender-sensitive support programmes can create a healthier future for all. The revision of the EU Tobacco Products Directive is an opportunity for Europe to legislate plain packaging, banning the use of slim packages that specifically appeal to young girls, and include strong health warnings that are gender based. A new robust EU Alcohol Strategy must be agreed and implemented speedily. This Strategy should develop effective policies and enforce strict labelling and health warnings by the alcohol industry. Both tobacco and alcohol industry marketing practices that specifically target young girls must be banned.”
You can download this press release (.doc) at …more
For more information:
Peggy Maguire, Director General, email@example.com
Hildrun Sundseth, Head of EU Policy, firstname.lastname@example.org
Gerhard Steffes is working as a Policy Officer for the European Commission Directorate for Health and Consumers (SANCO). Within the unit “Programme and Knowledge Management,” Gerhard Steffes is responsible for the development and the implementation of communication strategies, including the conceptual design and management of the European anti-tobacco campaign “Ex-smokers are unstoppable.”
He is working as a project manager for the European Commission since 1994 in various domains of Public Health (SANCO) and Environmental Statistics (European Statistical Office). In 2009, he has been seconded as a European Expert to the African Union Headquarter in Addis Ababa. His academic background includes management studies, social sciences and political sciences. He earned a Master Degree from the University for Administration and Legal Affairs in Berlin and was awarded a Ph.D. Degree for his interdisciplinary doctoral studies on the regional European integration process.
Professor Joe Barry has held the Chair of Population Health Medicine in Trinity College since 2009, having previously held the position of Senior Lecturer, with a concomitant post as Specialist/Consultant in Public Health in the Health Service Executive. Professor Barry takes a programmatic and thematic approach to research into problem substance use and addiction. The substances range from alcohol to illicit drugs such as heroin and cocaine and prescribed medications such as methadone and benzodiazepines.His research includes cross sectional surveys, intervention studies, cohort studies, health outcome studies such as mortality and survival analysis, general health, social and economic impact studies, prevalence of use studies, behavioural and attitude studies, policy analysis, neuroscanning and Cochrane reviewing.
His research findings have been widely published and presented at both national and international levels and have been used to influence policy. Professor Barry served as head of Public Health & Primary Care in Trinity College from 2006 – 2012. He acted as Interim Deputy Head of the School of Medicine in Trinity College during 2012 and is the School Director of Policy and Engagement. He has served in various capacities on a variety of public bodies, both academic and professional. He was Dean of the Faculty of Public Health Medicine of the RCPI for two consecutive terms, 1997 – 2002. He has served on the National Drug Strategy Team and the National Advisory Committee on Drugs. He is currently Chair of the North Inner City Local Drugs Task Force and is a board member of Alcohol Action Ireland and of the Irish Penal Reform Trust.
Professor Linda Bauld is Professor of Health Policy at the University of Stirling. She has a background in applied policy research and for the past 15 years her research interests have centered on the evaluation of public health interventions. She has conducted studies on drug and alcohol use, inequalities in health and on tobacco control and smoking cessation. She is a former scientific adviser on tobacco control to the Department of Health and currently chairs a number of public health advisory and funding committees for NICE, Cancer Research UK and the Scottish government.
Examples of her recent work include conducting the UK government’s 2011 review of the impact of smoke free legislation in England and examining the experiences of problem drug users accessing benefits to inform recent DWP welfare reforms. From June 2013 she will become Deputy Director of the UK Centre for Tobacco and Alcohol Studies, a UK Centre for Public Health Excellence that covers 13 Universities.
Joanne Vance is the Senior Health Promotion Officer at the Irish Cancer Society. A history graduate and social researcher, Joanne has worked for 20 years designing, delivering and evaluating community-based education and awareness raising programmes to promote equality and to address the exclusion of disadvantaged groups, particularly women, people with disabilities, and unemployed people.
Having completed her MSc in Economic Policy Evaluation, she moved into the health policy reform arena, with the National Women’s Council, specialising in health inequalities, and primary care. Joining the Irish Cancer Society in 2010, she co-designed the X-HALE Youth Awards, a smoking prevention initiative, which engages young people from communities where smoking is an issue. A strong interest in understanding how gender impacts in health service design and delivery; she is a member of the Health Service Executive’s Gender Mainstreaming National Advisory Group.
Kevin O’ Hagan is the Health Promotion Manager at the Irish cancer Society. He has worked in the field of Health Promotion in both the public and voluntary sector. He was seconded form his teaching position in 2000 to the post of Regional Manager for Social, Personal and Health Education (SPHE) in Post-primary schools. In this role he assisted schools in implementing the SPHE programme; delivering training to teachers and assisting schools in developing policies to promote the health and personal development of students.
Previous to joining the Irish Cancer Society Kevin was Programme Manager for the National Youth Health Programme where he managed the Health Quality Award process, which promotes quality youth health promotion practice within 40 community and voluntary youth organisations. He has postgraduate training in Education, Health Promotion, Youth and Community work and Psychotherapy.
Panel of experts
Liam McCormack is responsible for policy on alcohol in the Irish Department of Health. He graduated from UCD in 1993 (BComm) and spent a number of years working as a computer systems analyst in the Civil Service.
He joined the Department of Health in December 2000 and has worked in a number of policy areas; his last role involved drafting legislation. His current role is to develop policy on alcohol, especially in the context of the National Substance Misuse Strategy report.
Marion Rackard is an accredited addiction counsellor (IAAAC) and psychotherapist (IAHIP). Manager of a HSE community based alcohol counselling service for south west Dublin from 1990-2004. Director of a National Counselling service(ALBA) 2004-2006. Executive Director of Alcohol Action Ireland 2006-2008. Since 2008, she has been working in the national office for addiction in Social Inclusion on a variety of substance misuse projects with a remit for education and training and the substance misuse strategy.
Florence Berteletti Kemp is a public health and tobacco-control advocate. She works as a consultant on European Union health policy to the Smoke Free Partnership (SFP) in Brussels and was appointed to lead the organisation in 2009. Ms. Berteletti Kemp has worked on policies related to tobacco control in the European Union and at International since 2005 when she joined SFP.
Her work involves leading the development of political strategies to ensure the implementation of the Framework Convention on Tobacco Control (FCTC), and in particular FCTC Art 11 & 13 (packaging, labeling and advertising of tobacco products), FCTC Art 6 (Tobacco Tax Directive and measures related to the price and affordability of tobacco), FCTC Art 5.3 (tobacco industry interference in tobacco control policy) and FCTC Art 8 (smoke free policies). Her work also involves leading and coordinating major pan-European projects, including TobTaxy, a capacity building project, which ran from September 2010 to November 2012.She is also a member of DG SANCO Stakeholder’s Dialogue Group.
Ger McHugh has worked with Foróige, the National Youth Development Organisation since 2007, as Drugs Misuse Prevention Project Officer. Ger facilitates Drug Awareness Training for Foróige staff and volunteers, policy review and development, consultancy and support for programme design and promotes best practice in drug prevention education initiatives. Ger is currently leading the development of and training in Foróige’s new Health and Well-being programme Be Healthy, Be Happy.
Ger holds a Degree in Social Science, a Certificate in Addiction Studies and a Specialist Certificate in Youth Health Promotion. Ger represents the National Youth Council of Ireland on the NACD prevention sub-group. Previous to her work in Foróige, Ger was employed in Focus Ireland, working with people out of home, for 8 years.
Norma Cronin is a tobacco control specialist with a particular interest in smoking cessation and training and over 20 years experience in this area. She is a board member of ASH Ireland and an advisory board member of INWAT Europe, the International Network of Women Against Tobacco.
A trained general and public health nurse, she is the former health promotion manager at the Irish Cancer Society with overall responsibility for cancer prevention and tobacco control. She is also a former chairperson of the Office for Tobacco Control.
European Institute of Women’s Health
Peggy Maguire, the Director General of the European Institute of Women’s Health, is a political scientist and has been working at EU level highlighting the need for gender equity in health. She has worked with the Commission on various expert committees including the External Advisory Group on ageing and disability and EU Commission expert group on gender in FP6 and WHO expert group on gender mainstreaming. Peggy has initiated many research projects and publications on behalf of the European Institute of Women’s Health, including the development of a cancer information site for women and families. Recently, she co-ordinated the Institute’s contributions to the DG SANCO co-funded ENGENDER project and DG CONNECT co-funded, iSAC6+information project. Peggy has been an evaluator for FP6 and FP7 funding programmes over the last numbero of years. Her publications include: Women’s Health in Europe-Facts and Figures across the EU; Discrimination Against Women and Young Girls in Health Sector; Reducing Health Inequalities, Dementia Care challenges for an Ageing Europe.
Hildrun Sundseth is the Head of EU Policy and a Board Member of the EIWH. She is responsible for the Institute’s strategy and advocacy for an equitable and gender-sensitive approach in health policy, research, treatment and care. In the past, Hildrun headed the Brussels office of the European Cancer Patient Coalition, a patient-led umbrella organisation representing cancer patient groups from across the EU.
She was instrumental in encouraging the European Parliament to set up the forum MEPs against Cancer, and worked with the Slovenian EU Presidency to make cancer control once more a priority for EU Action. This resulted in the European Partnership Action against Cancer (EPAAC) under whose patronage the European Week against Cancer is being held. Hildrun sits on the FP7 project EHR4CT Ethics advisory committee and the EUROmediCAT Patient advisory committee. She represents the EIWH at the European Medicines Agency.
Hildrun has made various presentations on women’s health including to the European Parliament Women’s Rights and Gender Equality (FEMM) Committee and the European Economic and Social Committee (EESC) hearing on Tobacco Control.
1Irish Times. 28 May 2013. “Plain cigarette packets to be launched.” http://www.irishtimes.com/news/health/plain-cigarette-packets-to-be-introduced-1.1408747
2European Monitoring Centre for Drugs and Drug Addiction. 2011. Summary: 2011 ESPAD Report. http://www.espad.org/Uploads/ESPAD_reports/2011/The_2011_ESPAD_Report_FULL_2012_10_29.pdf.
COST is an EU framework that is helping improve the integration of women into science and technology. It has had some success, e.g. promoting the careers of women in science and technology through structural changes in institutions.
They try to equal men and women in the science and technology area and they can exhibit something,that they accomplished. For example a better promoting in gender integration in science, research and technology.
In December 2009 the COST Committee of Senior Officials (CSO) approved a strategy towards
increased support of early stage researchers. This strategy also included a family-friendly policy in order to promote gender equality in research environments.
At least is to say that COST is a good framework and they have success in it what they do, and women can be lucky that there is a cooperation like COST they try to equal men and women in technology and science area. Also they deploy for a family-friendly policy what is a good thing for the publication …. more ….Download PDF
Women’s power going even further down?
Over 80 years ago, women got the vote and its about 40 years since the Sex Discrimination Act was passed in the UK. Women, who form the majority of the population, do not appear to have achieved or improved their position particularly as public sector decision makers.
In UK politics and other areas, mostly public sector decision making, about 20 % is done by women.
The rate of UK female members in European Parliament is barely over 30%. In the National
Assembly for Wales 41.7% of the members are women, the area with the highest female
rate. It looks, using this report, which compares figures between 2003 to 2012, little progress,
if any, has been achieved.
The rate of women in the Cabinet has fallen by 6%, making Britain one of the lowest placed locations for achieving equality in the EU.
The minority, men, retain the majority….. more
From clause to effect : including women’s rights and gender in peace agreements
An E book by Cate Buchanan, published by Geneva: Centre for humanitarian dialogue, 2012 in English.
Report from the Centre for Humanitarian Dialogue six peace agreements from the Asia-Pacific region are examined on five theme’s: power-sharing, resource-sharing, security arrangements, access to justice and monitoring. The report looks at how women’s rights are included or excluded in agreements and recommends improvements in texts of the agreements where these are possible.…. more
Experts urge more gender balance in clinical trials.
Too few women take part in clinical tests to develop new drugs, putting their lives at risk as women’s bodies react differently to medicines, health experts said ahead of International Women’s Day.
Cardiovascular disease causes 40% of all deaths in the EU but has traditionally been regarded as a male disease, so keeping women largely out of clinical trials to develop new drugs. But cardiovascular disease is a leading cause of death among women and this one-size-fits-all approach is putting women’s health at risk, according to experts.
Marco Stramba-Badiale, director of the Department of Geriatrics and Cardiovascular Medicine at IRCCS Istituto Auxologico Italiano in Milan, said regulatory agencies should adopt strict rules on the inclusion of women in clinical trials and a systematic gender analysis.
“The gender balance should become a formal requirement and not only a recommendation for the performance of clinical trials,” ….more